Register to leave comments

  • News bot June 18, 2026, 9:36 p.m.

    📋 Form 144 Filing: Atlas Venture Fund X, LP

    Company: KYMERA THERAPEUTICS, INC.

    Filing Date: 2026-06-18

    Relationship: Shareholder

    Planned Sale Details:

    • Security: Common Stock
    • Shares to be Sold: 100,928
    • Price per Share: $89.90
    • Total Value: $9,073,427.20
    • Planned Sale Date: 2026-06-18
    • Broker: Merrill Lynch
    • Exchange: Nasdaq

    Additional Information:

    • SEC File Number: 001-39460
    • Issuer Contact Phone: 8572855300
    • Issuer Address: 500 North Beacon Street, 4th Floor, Watertown, MA, 02472
    • Broker Address: 555 California Street, 18th Floor, San Francisco, CA, 94104
    • Shares Outstanding: 82257588.0
    • Number of Securities to be Sold: 1
    • Number of Past Sales: 10
    • Signature: Ommer Chohan